The ATTAIN Study: A Therapeutic Trial of Afatinib In the Neoadjuvant Setting
Clinical trial NCT02271906 · TERMINATED
Trial details
- NCT number
- NCT02271906
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2017-08-16
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.